EMVision bags $1.75m manufacturing grant payment
Brain imaging company EMVision Medical Devices Limited has received a cash progress payment of $1,750,000 under its Modern Manufacturing Initiative (MMI) grant award.
Vocational apprenticeship completion rates drop in latest industry report
Completion rates for apprentices and trainees who began training in 2017 decreased to 55.7 per cent, a 1.2 per cent drop compared to the...
Global 3D printing high-performance plastic market expected to grow at 8.5% CAGR by 2029
The market for high-performance plastics used in 3D printing is expected to expand significantly between 2023 and 2029, with a compound annual growth rate (CAGR) of 8.45 per cent, reaching a value of USD 184.5 million by that year, according to market research firm BlueWeave Consulting.
Sparc Technologies secures nearly $1 million in R&D tax refund
Australian graphene production company Sparc Technologies has received a $934,195 research and development tax refund as part of the Australian government’s R&D tax incentive, relating to the 2022 financial year.
Orica reports surge in full-year net profit, forecasts earnings boost for FY24
Mining and infrastructure solutions developer Orica Limited has revealed robust financial results for the year ending 30 September 2023, showcasing a significant uplift in performance driven by effective strategy execution and commercial discipline.
DroneShield sees 2022 revenue spike to 60%
ASX-listed DroneShield has released its 2022 annual report, with another record year of revenue up by 60 per cent to $16.9 million.
Rio Tinto reports manufacturing-facing metals drive production growth in 2025
Rio Tinto has reported an 8 per cent year-on-year increase in copper equivalent production for 2025 and record quarterly output across several product groups, according to its latest ASX operations review.
Immuron prepares for diarrhoea-focused clinical trial as US FDA lifts clinical hold
Immuron, an Australia-based biopharmaceutical company, is slated to move forward with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) following approval from the US Food and Drug Administration (FDA).
CIMIC’s Sedgman buys Canadian engineering and metallurgy company Novopro
Sedgman, a CIMIC Group subsidiary, has acquired Novopro Projects Inc, a Canadian engineering and metallurgy firm that provides technical services and process equipment to projects in North America, Europe, Africa, the Middle East, and Australia.
Small business optimism declines as expectations for better business conditions worsens in December
The NFIB Small Business Optimism Index declined 2.1 points in December to 89.8, marking the 12th consecutive month below the 49-year average of 98.



























